Cargando…
Pulmonary arterial hypertension drugs can partially restore altered angiogenic capacities in bmpr2‐silenced human lung microvascular endothelial cells
Mutations in the bone morphogenetic protein receptor type 2 (bmpr2) gene and signaling pathway impairment are observed in heritable and idiopathic pulmonary arterial hypertension (PAH). In PAH, endothelial dysfunction is currently handled by drugs targeting the endothelin‐1 (ET‐1), nitric oxide (NO)...
Autores principales: | Tielemans, Birger, Wagenaar, Allard, Belge, Catharina, Delcroix, Marion, Quarck, Rozenn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543474/ https://www.ncbi.nlm.nih.gov/pubmed/37790139 http://dx.doi.org/10.1002/pul2.12293 |
Ejemplares similares
-
Cytokines trigger disruption of endothelium barrier function and p38
MAP kinase activation in BMPR2-silenced human lung
microvascular endothelial cells
por: Tielemans, Birger, et al.
Publicado: (2019) -
Incremental Experience in In Vitro Primary Culture of Human Pulmonary Arterial Endothelial Cells Harvested from Swan-Ganz Pulmonary Arterial Catheters
por: Tielemans, Birger, et al.
Publicado: (2021) -
Learning from registries in pulmonary arterial hypertension: pitfalls and recommendations
por: Swinnen, Katleen, et al.
Publicado: (2019) -
The Cellular Landscape of Chronic Thromboembolic Pulmonary Hypertension Revealed by Single-Cell Sequencing: Therapeutic Implications?
por: Quarck, Rozenn, et al.
Publicado: (2023) -
COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
por: Belge, Catharina, et al.
Publicado: (2020)